EP 2847175 A1 20150318 - COMPOSITIONS AND METHODS FOR SUPPRESSION OF CARBONIC ANHYDRASE ACTIVITY
Title (en)
COMPOSITIONS AND METHODS FOR SUPPRESSION OF CARBONIC ANHYDRASE ACTIVITY
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR UNTERDRÜCKUNG VON CARBOANHYDRASEAKTIVITÄT
Title (fr)
COMPOSITIONS ET MÉTHODES INHIBANT L'ACTIVITÉ DE L'ANHYDRASE CARBONIQUE
Publication
Application
Priority
- IN 1810CH2012 A 20120508
- IB 2013050899 W 20130203
Abstract (en)
[origin: WO2013167994A1] Provided are the compounds of formula (I) or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula (I), and methods for treating or preventing or modulating carbonic anhydrase activity in a disease may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral admimstration, syrup, or injection. Such compositions may be used to treatment of glaucoma, epileptic seizures, Idiopathic intracranial hypertension (pseudotumor cerebri), altitude sickness, cystinuria, periodic paralysis and dural ectasia, congestive heart failure, drug induced edema, diuretic, intermittent claudication resulting from obstructed arteries in the limbs, and vascular dementia.
IPC 8 full level
C07D 285/135 (2006.01); A61K 31/433 (2006.01); A61P 27/06 (2006.01)
CPC (source: CN EP)
A61P 1/08 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 7/00 (2017.12 - EP); A61P 7/10 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/04 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 11/08 (2017.12 - EP); A61P 13/02 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 15/08 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 27/06 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 285/135 (2013.01 - CN EP); C07D 417/12 (2013.01 - CN EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2013167994 A1 20131114; AU 2013257715 A1 20141127; AU 2013257715 B2 20160505; CA 2872978 A1 20131114; CN 104364241 A 20150218; EP 2847175 A1 20150318; EP 2847175 A4 20160420; JP 2015520748 A 20150723; SG 11201407317S A 20141230
DOCDB simple family (application)
IB 2013050899 W 20130203; AU 2013257715 A 20130203; CA 2872978 A 20130203; CN 201380030632 A 20130203; EP 13787577 A 20130203; JP 2015510896 A 20130203; SG 11201407317S A 20130203